Related Experiment Video
Updated: Jan 8, 2026

Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
Published on: January 20, 2015
Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver
Xinping Tan1, Udayan Apte, Amanda Micsenyi
1Department of Pathology, University of Pittsburgh, School of Medicine, Pennsylvania 15261, USA.
Background & Aims:
Wnt/beta-catenin activation is observed in normal liver development, regeneration, and liver cancer. Our aim was to elucidate the regulation and mechanism of this pathway in liver.
Methods:
We report the generation and characterization of liver-specific nonmutated beta-catenin-overexpressing transgenic mice. Transgenic livers were examined for their morphology and phenotype by histology, proliferation, apoptosis, and microarray analysis.
Results:
Transgenic livers displayed a significant increase in cytoplasmic, membranous, and nuclear beta-catenin in hepatocytes as compared with their wild-type littermates, which display a predominant membranous localization only. A 15%-20% increase in the liver weight-body weight ratio was evident in transgenic mice secondary to increased hepatocyte proliferation. Microarray analysis showed differential expression of approximately 400 genes in the transgenic livers. Epidermal growth factor receptor RNA and protein and increased levels of activated epidermal growth factor receptor and Stat3 were observed in the transgenic livers. Epidermal growth factor receptor promoter analysis showed a T-cell factor-binding site, and subsequent reporter assay confirmed epidermal growth factor receptor activation in response to Wnt-3A treatment that was abrogated by frizzled related protein 1, a known Wnt antagonist. Epidermal growth factor receptor inhibition successfully decreased liver size in transgenic mice. Next, 7 of 10 hepatoblastomas displayed simultaneous beta-catenin and epidermal growth factor receptor up-regulation, thus suggesting a strong relationship between these 2 proteins in tumors.
Conclusions:
beta-Catenin transgenic mice show an in vivo hepatotrophic effect secondary to increased basal hepatocyte proliferation. Epidermal growth factor receptor seems to be a direct target of the pathway, and epidermal growth factor receptor activation might contribute toward some mitogenic effects of increased beta-catenin in liver: epidermal growth factor receptor inhibition might be useful in such states.
Insights
Wnt/beta-catenin pathway activation in liver increases hepatocyte proliferation and liver size. Epidermal growth factor receptor (EGFR) is a direct target, and its inhibition may reduce liver overgrowth in certain conditions.
Area of Science:
- Hepatology
- Molecular Biology
- Cancer Research
Background:
- Wnt/beta-catenin signaling is crucial for liver development, regeneration, and cancer.
- Understanding its regulation and mechanisms in the liver is essential.
Purpose of the Study:
- To elucidate the regulation and mechanism of Wnt/beta-catenin pathway in liver.
- To investigate the role of beta-catenin overexpression in liver growth and gene expression.
Main Methods:
- Generation and characterization of liver-specific beta-catenin-overexpressing transgenic mice.
- Analysis of liver morphology, proliferation, apoptosis, and gene expression via histology and microarray.
- Reporter assays to confirm gene activation and inhibition studies.
Main Results:
- Transgenic livers showed increased beta-catenin in hepatocytes, leading to a 15-20% increase in liver weight due to enhanced hepatocyte proliferation.
- Microarray analysis revealed differential expression of ~400 genes, including upregulation of epidermal growth factor receptor (EGFR) and activated Stat3.
- EGFR promoter analysis identified a T-cell factor-binding site, confirming EGFR as a direct target of the Wnt pathway. EGFR inhibition reduced liver size in transgenic mice.
- Hepatoblastomas frequently showed co-upregulation of beta-catenin and EGFR.
Conclusions:
- Overexpression of beta-catenin induces a hepatotrophic effect in vivo, increasing basal hepatocyte proliferation.
- Epidermal growth factor receptor (EGFR) is a direct target of the Wnt/beta-catenin pathway in the liver.
- EGFR activation contributes to the mitogenic effects of beta-catenin, suggesting EGFR inhibition as a potential therapeutic strategy for beta-catenin-driven liver overgrowth.
Related Concept Videos
09:21Phenotypic Profiling of Human Stem Cell-Derived Midbrain Dopaminergic Neurons
10:54Reliable Identification of Living Dopaminergic Neurons in Midbrain Cultures Using RNA Sequencing and TH-promoter-driven eGFP Expression
08:45Isolation, Culture and Long-Term Maintenance of Primary Mesencephalic Dopaminergic Neurons From Embryonic Rodent Brains
09:35Environmental Modulations of the Number of Midbrain Dopamine Neurons in Adult Mice
11:58Primary Culture of Mouse Dopaminergic Neurons
09:54Comprehensive Profiling of Dopamine Regulation in Substantia Nigra and Ventral Tegmental Area

